Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04832698 · ClinicalTrials.gov registry record
Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training
A clinical trial of Malignant Vascular Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 9
- Enrollment target
- 1
- Study location
NCT04832698 is a study of Malignant Vascular Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 9 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04832698, a study of Malignant Vascular Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This study looks at the comfort of interventional and diagnostic imaging residents in performing simulated endovascular procedures after completing training on the Mentice endovascular simulator device. Implementation of a training curriculum with radiology residents interested in interventional radiology will help facilitate hands-on training in a low-risk environment and allow for safer future patient encounters.
Conditions Studied
Interventions
- OTHER Survey Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-07-08 |
| Est. Completion | 2026-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04832698
The ClinicalTrials.gov registry entry for NCT04832698 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Vascular Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Survey Administration is the first listed.
NCT04832698 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04832698 about?
NCT04832698 is a clinical study titled "Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training". This study looks at the comfort of interventional and diagnostic imaging residents in performing simulated endovascular procedures after completing training on the Mentice endovascular simulator device. Implementation of a training curriculum with radiology residents interested in interventional rad...
What is the current status of trial NCT04832698?
This trial is currently recruiting. The enrollment target is 9 participants. The study started on 2020-07-08. Estimated completion is 2026-04-30.
What conditions does trial NCT04832698 study?
This clinical trial studies the following conditions: Malignant Vascular Neoplasm.
What interventions are being tested in trial NCT04832698?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT04832698?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04832698 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.